journal article·2007-12-17

InGaP@ZnS‐Enriched Chitosan Nanoparticles: A Versatile Fluorescent Probe for Deep‐Tissue Imaging

M. G. Sandros, M. Behrendt, D. Maysinger, M. Tabrizian

Advanced Functional Materials· Volume 17· Issue 18
Publisher page

Abstract

Abstract InGaP QDs overcoated with several monolayers of ZnS are covalently bound to chitosan to address the challenges of developing highly biologically stable and fluorescent nanoparticle probes for deep‐tissue imaging. Transmission electron microscopy images reveal that the average diameter of these luminescent nanoparticles is approximately 29 nm, and they contain multiple InGaP@ZnS QDs that have an average diameter between 4 and 5 nm. These new InGaP@ZnS–chitosan nanoparticles emit near the near IR region at 670 nm and are able to penetrate three times deeper into tissue (e.g., even through a mouse skull) while revealing a higher uptake efficiency into PC12 cells with a robust signal. Additionally, a cell viability assay demonstrates that these new fluorescent nanoparticles have good biocompatibility and stability with PC12 cells and neural cells. As a result, these near‐IR‐emitting nanoparticles can be used for real‐time and deep‐tissue examination of diverse specimens, such as lymphatic organs, kidneys, hearts, and brains, while leaving the tissue intact.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Quantum Dots Synthesis And Properties · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. 10.1152/jn.01007.200310.1152/jn.01007.2003 ↗
2. 10.1126/science.108378010.1126/science.1083780 ↗
3. 10.1021/nl034733410.1021/nl0347334 ↗
4. 10.1289/ehp.828410.1289/ehp.8284 ↗
5. 10.1111/j.1348-0421.2004.tb03478.x10.1111/j.1348-0421.2004.tb03478.x ↗
6. 10.1039/b413175d10.1039/b413175d ↗
7. 10.1016/j.cis.2006.05.02610.1016/j.cis.2006.05.026 ↗
8. 10.1038/nbt92010.1038/nbt920 ↗
9. 10.1038/nbt118810.1038/nbt1188 ↗
10. 10.1162/15353500376527628210.1162/153535003765276282 ↗
11. 10.1002/smll.20050010510.1002/smll.200500105 ↗
12. 10.1021/jp026380n10.1021/jp026380n ↗
13. 10.1039/b606572b10.1039/b606572b ↗
14. 10.1038/9022810.1038/90228 ↗
15. 10.1021/ac035460010.1021/ac0354600 ↗
16. 10.1039/b307500a10.1039/b307500a ↗
17. 10.1002/adma.20030611110.1002/adma.200306111 ↗
18. 10.1016/j.biomaterials.2005.09.00410.1016/j.biomaterials.2005.09.004 ↗
19. 10.1016/j.bbrc.2005.03.22810.1016/j.bbrc.2005.03.228 ↗
20. 10.1039/b509781a10.1039/b509781a ↗
21. 10.1016/j.jcis.2007.01.08310.1016/j.jcis.2007.01.083 ↗
22. 10.1016/j.stam.2006.09.00810.1016/j.stam.2006.09.008 ↗
23. 10.1002/jbm.a.3041010.1002/jbm.a.30410 ↗
24. 10.1088/0957-4484/17/1/02210.1088/0957-4484/17/1/022 ↗
25. 10.3109/1073119900911728610.3109/10731199009117286 ↗
26. 10.1016/0378-5173(92)90353-410.1016/0378-5173(92)90353-4 ↗
27. 10.1163/156856205284333910.1163/1568562052843339 ↗
28. 10.1016/j.jconrel.2004.08.01010.1016/j.jconrel.2004.08.010 ↗
29. Patrick E. · Pharm. Res. · 1998 · 15 · 133210.1023/A:1011981000671 ↗
30. 10.1089/hum.1998.9.12-170910.1089/hum.1998.9.12-1709 ↗
31. 10.1016/S0005-2736(01)00362-510.1016/S0005-2736(01)00362-5 ↗
32. 10.1021/la960187110.1021/la9601871 ↗
33. 10.1562/0031-8655(2002)0750327FQYATR2.0.CO210.1562/0031-8655(2002)0750327FQYATR2.0.CO2 ↗
34. 10.1021/nl034086g10.1021/nl034086g ↗
35. 10.1002/masy.1999144013710.1002/masy.19991440137 ↗
36. 10.1021/ja054166h10.1021/ja054166h ↗
37. 10.1364/AO.46.00165010.1364/AO.46.001650 ↗
38. 10.1088/0031-9155/50/11/E0110.1088/0031-9155/50/11/E01 ↗